Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
CureLink AB
AB
Active
Org 5592170194
Esplanaden 15 B, 234 39
Lomma
Temporary employment agency activities and other human resource provisions
·
NACE 7820
Est. 2019 · 6 years old
1-4 employees
Monitor
Share
Sweden
/
Companies
/
Temporary employment agency activities and other human resource provisions
/
CureLink AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
56M
42M
28M
14M
0M
2021: 20M
20M
2021
2022: 27M (+35% vs 2021)
27M
+35%
2022
2023: 30M (+11% vs 2022)
30M
+11%
2023
2024: 34M (+13% vs 2023)
34M
+13%
2024
2025: 45M (+32% vs 2024)
45M
+32%
2025
EBITDA
SEK millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
45 079
34 105
30 446
27 126
20 044
Staff expenses
−3 017
—
—
—
—
EBITDA
901
745
1 211
1 034
1 227
Depreciation & amort.
—
−0
−0
−0
−0
EBIT
901
745
1 211
1 034
1 227
Net financials
5
8
−4
−2
−2
Profit before tax
906
753
1 207
1 032
1 226
Tax
−195
−165
−260
−223
−258
Net profit
710
588
947
809
968
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
7 607
8 749
6 812
5 757
4 787
Equity
1 899
1 689
1 851
1 704
1 255
Long-term debt
220
220
220
400
400
Short-term debt
5 488
6 840
4 741
3 653
3 133
Total debt
5 708
7 060
4 961
4 053
3 533
Financial ratios
5-year trend
EBITDA margin
2,0 %
This company
15,8 %
Market median
This company
Market median
87% below market
2021
2025
Equity ratio
25,0 %
This company
38,2 %
Market median
This company
Market median
35% below market
2021
2025
Return on equity
37,4 %
This company
18,4 %
Market median
This company
Market median
103% above market
2021
2025
Net profit margin
1,6 %
This company
8,1 %
Market median
This company
Market median
80% below market
2021
2025
Asset turnover
5,93×
This company
1,12×
Market median
This company
Market median
429% above market
2021
2025
Debt / equity
3,01×
This company
0,62×
Market median
This company
Market median
385% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on CureLink AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
